Month: December 2020

BALA CYNWYD, Pa., Dec. 07, 2020 (GLOBE NEWSWIRE) — Global Indemnity Group, LLC (NASDAQ:GBLI) (the “Company”) announced today its Board of Directors has approved a distribution payment of $0.25 per common share to be paid on December 31, 2020 to all shareholders of record as of the close of business on December 24, 2020.About Global Indemnity Group, LLC and its subsidiariesGlobal Indemnity Group, LLC (NASDAQ:GBLI), through its several direct and indirect wholly owned subsidiary insurance companies, provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. Global Indemnity Group, LLC’s four primary segments are:Commercial SpecialtySpecialty PropertyFarm, Ranch, & StableReinsuranceFor more information,...

BUFORD, Ga., Dec. 07, 2020 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or “the Company”) announced today that it has completed the previously announced acquisition of Tom George Yacht Group (“TGYG”). TGYG enhances the Company’s presence on the west coast of Florida and expands new and pre-owned boat sales, as well as yacht brokerage and service & parts.“We are excited to have resumed our successful acquisition strategy with the addition of TGYG. Since 2014, we have successfully acquired 40 retail locations. TGYG marks our first since going public in early fiscal year 2020, and is one of the largest acquisitions in our history. We have a strong track record delivering operational synergies and fueling margin expansion by working collaboratively with our dealers, and TGYG will be no different. We look forward...

San Diego, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a preclinical-stage biopharmaceutical company focused on developing proprietary molecules with strong clinical and commercial differentiation, announced today that Punit Dhillon, CEO, Emerald Bioscience will be present a corporate overview at the Benzinga Global Small Cap Virtual Conference taking place on December 8-9, 2020.Presentation details are as follows:Event: Benzinga Global Small Cap Virtual ConferencePresentation Date: Wednesday, December 9, 2020Presentation Time: 12:00 – 12:15 PM ETFor more information and/or to register for the conference please visit: https://events.benzinga.com/registration-pageAbout Emerald Bioscience, Inc.Emerald Bioscience Inc. is a biopharmaceutical company focused on the discovery...

HOUSTON, Dec. 07, 2020 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter and fiscal year ended September 30, 2020.Fourth Quarter 2020 HighlightsRevenue of $330 million for the fourth quarter of fiscal 2020, an increase of 13% compared with $294 million for the fourth quarter of fiscal 2019Operating income of $14.4 million for the fourth quarter of fiscal 2020, an increase of 4% compared with $13.9 million for the same quarter of fiscal 2019. Operating income for 2020 included a goodwill impairment charge of $7.0 million and executive severance charges of $1.8 millionNet income attributable to IES of $14.6 million, or $0.68 per diluted share, for the fourth quarter of fiscal 2020, compared with $9.9 million, or $0.46 per diluted share, for the same quarter...

BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the subscription period for its previously announced rights offering of shares of the Company’s common stock at a subscription price of $1.07 per share expired on December 4, 2020, and these rights are no longer exercisable.Based on a review of preliminary results provided by the Company’s subscription agent, EQ Shareowner Services, the Company expects to issue approximately 711,143 shares of common stock in the rights offering. The Company expects to receive gross proceeds of approximately $761,000 from the rights offering. The results of the rights offering and the Company’s estimates regarding the gross...

NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq: RPRX) and Athyrium Capital Management, LP today announced transactions totaling $325 million in funding for BioCryst, with $250 million available at closing, to support the launch of ORLADEYO™ (berotralstat) in hereditary angioedema (HAE) and the development of its oral Factor D inhibitor, BCX9930.Royalty Pharma will provide BioCryst with an upfront cash payment of $125 million and will receive royalties of 8.75% on direct annual net sales of ORLADEYO up to $350 million, 2.75% on sales between $350 million and $550 million, no royalty on sales over $550 million, and a tiered percentage of sublicense revenue for ORLADEYO in certain territories. In addition, Royalty Pharma will receive...

VANCOUVER, British Columbia, Dec. 07, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telehealth company seeking to revolutionize the delivery of healthcare to patients, is excited to announce it is expanding its already established relationship with Save-On-Foods, Western Canada’s largest grocery chain, to provide an on-demand telemedicine service to its customers. Save-On-Foods has over 180 stores across BC, Alberta, Saskatchewan, Manitoba and the Yukon.Earlier this year, CloudMD and Save-On-Foods announced plans to pilot telemedicine kiosks in nine pharmacies across British Columbia. The kiosk enables customers to see a doctor for prescriptions and non-emergency health concerns in real time, on-site. After the virtual visit, prescriptions...

Company Completes ATM Offering – Raises $20 Million in Cash;Pays off $2.7 Million CrowdOut Capital DebtROSEVILLE, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Sunworks, Inc. (Nasdaq: SUNW), a provider of solar power solutions for agriculture, commercial and industrial (ACI), public works and residential markets, today announced the Company has sold approximately 3.8 million shares of common stock raising approximately $20 million in gross proceeds through “at the market” offerings under its prospectus supplement filed on November 25, 2020.   The Company used a portion of the proceeds from the sales of its common stock to fully repay the outstanding balance of approximately $2.7 million under its Loan Agreement with CrowdOut Capital, Inc.Chuck Cargile, Sunworks Chairman of the Board said, “We have successfully bolstered our balance sheet,...